Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium
Myriam Drysdale, Thor Hautekiet, Moushmi Singh, Joris Hautekiet, Linda Ludikhuyze, Vishal Patel, Daniel C Gibbons, Dorothée De Roeck, Kirsten Colpaert, Emily J Lloyd, Eva Van Braeckel
doi: https://doi.org/10.1101/2023.12.14.23298578
